Centre for Social Research in Health, UNSW Sydney, Sydney, Australia.
The Kirby Institute, UNSW Sydney, Sydney, Australia.
BMC Infect Dis. 2024 Nov 19;24(1):1317. doi: 10.1186/s12879-024-10214-5.
There exist multiple regulatory layers for point-of-care (POC) testing to be implemented within Australia. This qualitative analysis sought to understand the pre-market barriers and facilitators to scale-up infectious diseases POC testing in primary care settings at the national level.
Key informant interviews were undertaken with people (n = 30) working in high- level positions relevant to infectious diseases POC testing in Australia. Participants were recruited from federal and state health departments, industry, and nongovernment national peak bodies. The Unitaid scalability framework informed this analysis to understand barriers and enablers to creating access conditions and establishing country readiness for market access of POC tests.
Participants identified regulatory frameworks as significant barriers to market access. National strategies and advocacy were viewed as potential enablers to establishing country readiness. It was recommended that the national system for universal health care should fund infectious disease POC tests to ensure financial sustainability, though the existing pathology infrastructure was regarded as a likely inhibitor.
Current regulatory frameworks inhibit market access for infectious disease POC testing devices for use in the primary care setting. National advocacy is urgently needed to gain government support and align national policies with regulatory frameworks.
在澳大利亚,存在多个针对即时检测(POC)的监管层,需要在全国层面上在初级保健环境中实施。本定性分析旨在了解传染病 POC 检测在全国范围内扩大规模的上市前障碍和促进因素。
对与澳大利亚传染病 POC 检测相关的高级别职位的人员(n=30)进行了关键知情人访谈。参与者来自联邦和州卫生部门、行业和非政府国家级机构。联合国艾滋病规划署的可扩展性框架为分析提供了信息,以了解创造准入条件和建立国家对 POC 检测市场准入准备的障碍和促进因素。
参与者认为监管框架是市场准入的重大障碍。国家战略和宣传被视为建立国家准备的潜在促进因素。有人建议,全民健康保险的国家系统应该为传染病 POC 检测提供资金,以确保财务可持续性,尽管现有的病理学基础设施被认为是一个可能的障碍。
当前的监管框架阻碍了在初级保健环境中使用传染病 POC 检测设备的市场准入。迫切需要国家宣传,以获得政府支持,并使国家政策与监管框架保持一致。